Gen-Probe, Becton Dickinson deal

Becton Dickinson received a non-exclusive worldwide license to Gen-Probe's U.S. Patents Nos. 4,851,330 and 5,288,611, covering methods for detecting Candida species, Gardnerella vaginalis and Trichomonas vaginalis for diagnosing vaginosis and vaginitis.

In exchange, Gen-Probe received an undisclosed upfront payment and will receive royalties. Gen-Probe said the patents are in a disease category that is not of interest to the company. ...